Revilab SL-01

Longevity & Cellular Health

Also known as: Revilab SL 01, SL-01

Bioregulators (Revilab Series)Research phase: Clinical use in Russia, no Western trialsRegulatory: Not FDA-approved. Available as bioregulator supplement in Russia and from international suppliers.

Mechanism

Revilab SL-01 is a sublingual multi-peptide complex targeting the cardiovascular system. It combines several Khavinson bioregulatory peptides in a convenient sublingual delivery format for heart and blood vessel support.

Technical detail

Revilab SL-01 is a sublingual bioregulator complex containing a proprietary blend of short-chain peptides targeting cardiovascular tissue, including peptides analogous to those found in Ventfort (vascular), Chelohart (cardiac), and Vilon (thymic/immune) cytomax preparations. Sublingual delivery provides rapid mucosal absorption bypassing first-pass hepatic metabolism. The multi-peptide approach aims to simultaneously support endothelial function, myocardial metabolism, and immune-mediated vascular protection.

Build a personalized protocol with Revilab SL-01 →